Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Creative Medical Technology Holdings (CELZ) Debt to Equity (2016 - 2023)

Historic Debt to Equity for Creative Medical Technology Holdings (CELZ) over the last 15 years, with Q1 2023 value amounting to $0.0.

  • Creative Medical Technology Holdings' Debt to Equity fell 3688.92% to $0.0 in Q1 2023 from the same period last year, while for Mar 2023 it was $0.0, marking a year-over-year decrease of 3688.92%. This contributed to the annual value of $0.0 for FY2022, which is 3559.44% down from last year.
  • As of Q1 2023, Creative Medical Technology Holdings' Debt to Equity stood at $0.0, which was down 3688.92% from $0.0 recorded in Q4 2022.
  • In the past 5 years, Creative Medical Technology Holdings' Debt to Equity registered a high of $0.0 during Q1 2022, and its lowest value of -$0.97 during Q4 2020.
  • Its 5-year average for Debt to Equity is -$0.41, with a median of -$0.53 in 2019.
  • In the last 5 years, Creative Medical Technology Holdings' Debt to Equity plummeted by 6102.34% in 2021 and then soared by 10135.07% in 2022.
  • Quarter analysis of 5 years shows Creative Medical Technology Holdings' Debt to Equity stood at -$0.85 in 2019, then fell by 14.78% to -$0.97 in 2020, then skyrocketed by 100.14% to $0.0 in 2021, then plummeted by 35.59% to $0.0 in 2022, then rose by 7.04% to $0.0 in 2023.
  • Its last three reported values are $0.0 in Q1 2023, $0.0 for Q4 2022, and $0.0 during Q3 2022.